Medical devicemaker MicroTransponder wrapped up a $53 million Series E funding round led by US Venture Partners.
The raise also included participation from GPG Ventures, Exceller Hunt Ventures, Osage University Partners, Action Potential Venture Capital and the Vertical Group. The company said it will use the capital to commercialize its Vivistim vagus nerve stimulation system, an implantable...
